{"id":115458,"date":"2021-06-01T12:00:00","date_gmt":"2021-06-01T12:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=28765212876521"},"modified":"2021-06-01T12:00:00","modified_gmt":"2021-06-01T12:00:00","slug":"cardiac-marker-testing-market-worth-5-5-billion-by-2025","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/","title":{"rendered":"Cardiac Marker Testing Market worth $5.5 billion by 2025"},"content":{"rendered":"<p><img decoding=\"async\" width=\"1200\" height=\"627\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" srcset=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg 1200w, https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo-768x401.jpg 768w, https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo-1024x535.jpg 1024w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<p>According to the new market research report\u00a0<strong>\u201c<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/cardiac-marker-market-64885447.html?utm_source=prnewswire&#038;utm_medium=referral&#038;utm_campaign=paidpr\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Cardiac Marker Testing Market<\/a><strong>\u00a0by Product (Reagent, Instrument), Component (Troponin I &#038; T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) \u2013 Global Forecasts to 2025\u2033,<\/strong>\u00a0published by MarketsandMarkets<img decoding=\"async\" src=\"https:\/\/s.w.org\/images\/core\/emoji\/12.0.0-1\/72x72\/2122.png\" alt=\"\u2122\" class=\"wp-smiley\" style=\"height: 1em; max-height: 1em;\" \/>, the market is estimated to be\u00a0<span class=\"xn-money\">USD 3.6 billion<\/span>\u00a0in 2020 and projected to reach\u00a0<span class=\"xn-money\">USD 5.5 billion<\/span>\u00a0by 2025, at a CAGR of 8.9%.<\/p>\n<p><em>Browse in-depth TOC on\u00a0<\/em>\u201c<strong>Cardiac Marker Testing Market<\/strong>\u201c<\/p>\n<p><strong>102 \u2013 Tables<br \/>37 \u2013 Figures<br \/>167 \u2013 Pages<\/p>\n<p><\/strong><strong>Download PDF Brochure:\u00a0<\/strong><br \/><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=64885447&#038;utm_source=prnewswire&#038;utm_medium=referral&#038;utm_campaign=paidpr\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=64885447<\/a><\/p>\n<p>The growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent.<\/p>\n<p>The cardiac marker testing market includes major Tier I and II suppliers like Roche Diagnostics Ltd. (<span class=\"xn-location\">Switzerland<\/span>), Abbott Laboratories (US), Siemens Healthineers AG (<span class=\"xn-location\">Germany<\/span>), and Danaher Corporation (US). These suppliers have their manufacturing facilities spread across regions such as\u00a0<span class=\"xn-location\">North America<\/span>\u00a0and\u00a0<span class=\"xn-location\">Europe<\/span>. COVID-19 has impacted their businesses as well.<\/p>\n<p>The cardiac marker testing market is also faced a period of short-term negative growth, which can be attributed to factors such as\u00a0 a greater than 50% drop in the number of patients with cardiovascular conditions and those diagnosed with myocardial infarction. All areas of cardiology service provision sustained significant reductions, which included outpatient clinics, investigations, procedures, and cardiology community services such as cardiac rehabilitation.<\/p>\n<p><strong>Wide use of reagents and kits in all basic diagnostic activities in laboratories, academic institutes, and POC settings is expected to result in the segment occupying the majority of the cardiac marker testing market share<\/p>\n<p><\/strong>Growing number of cardiac marker testing procedures, accessibility to a wide range of cardiac biomarker reagents and kits, and the growing demand for reliable, specific, and faster detection of cardiovascular diseases at an early stage are the key growth factors for this segment.<\/p>\n<p><strong>Troponin I and T estimated to be the fastest-growing market<\/p>\n<p><\/strong>Troponin I and T is estimated to be the fastest-growing segment in the cardiac marker testing market. The large share of this segment can be attributed\u00a0 high sensitivity and specificity, long elevation times, and rapid prediction of outcome or mortality.<\/p>\n<p><strong><span class=\"xn-location\">North America<\/span><\/strong>\u00a0is estimated to be the largest market due increasing incidence of cardiovascular diseases, growing public and private investments, NIH support for the development of novel cardiac biomarkers, and the rising geriatric population.<\/p>\n<p><strong>Request Sample Pages:<br \/><\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=64885447&#038;utm_source=prnewswire&#038;utm_medium=referral&#038;utm_campaign=paidpr\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=64885447<\/a><\/p>\n<p><strong><span class=\"xn-location\">Asia Pacific<\/span>\u00a0likely to emerge as the largest cardiac marker testing market, globally<\/p>\n<p><\/strong><span class=\"xn-location\">Asia Pacific<\/span>\u00a0is estimated to be the fastest-growing market for cardiac marker testing during the forecast period. The\u00a0<span class=\"xn-location\">Asia Pacific<\/span>\u00a0market is driven due increased healthcare spending by a larger population base, healthcare infrastructure modernization, and the rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas) in\u00a0<span class=\"xn-location\">Asia Pacific<\/span>\u00a0countries.<\/p>\n<p>Roche Diagnostics Ltd. (<span class=\"xn-location\">Switzerland<\/span>), Abbott Laboratories (US), Siemens Healthineers AG (<span class=\"xn-location\">Germany<\/span>), and Danaher Corporation (US) are the key players in the global cardiac marker testing market.<\/p>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Mr. Ashish Mehra<br \/> MarketsandMarkets<img decoding=\"async\" src=\"https:\/\/s.w.org\/images\/core\/emoji\/12.0.0-1\/72x72\/2122.png\" alt=\"\u2122\" class=\"wp-smiley\" style=\"height: 1em; max-height: 1em;\" \/> INC.<br \/> 630 Dundee Road<br \/> Suite 430<br \/> Northbrook, IL 60062<br \/> USA : 1-888-600-6441<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\">Cardiac Marker Testing Market worth $5.5 billion by 2025<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to the new market research report&nbsp;&ldquo;Cardiac Marker Testing Market&nbsp;by Product (Reagent, Instrument), Component (Troponin I &amp; T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) &ndash; Global Forecasts to 2025&Prime;,&nbsp;published by MarketsandMarkets&trade;, the market is estimated to be&nbsp;USD 3.6 billion&nbsp;in 2020 and projected to reach&nbsp;USD 5.5 billion&nbsp;by [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\">Cardiac Marker Testing Market worth $5.5 billion by 2025<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-115458","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cardiac Marker Testing Market worth $5.5 billion by 2025 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiac Marker Testing Market worth $5.5 billion by 2025 - Business\" \/>\n<meta property=\"og:description\" content=\"According to the new market research report&nbsp;&ldquo;Cardiac Marker Testing Market&nbsp;by Product (Reagent, Instrument), Component (Troponin I &amp; T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) &ndash; Global Forecasts to 2025&Prime;,&nbsp;published by MarketsandMarkets&trade;, the market is estimated to be&nbsp;USD 3.6 billion&nbsp;in 2020 and projected to reach&nbsp;USD 5.5 billion&nbsp;by [&hellip;] The post Cardiac Marker Testing Market worth $5.5 billion by 2025 appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-01T12:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\",\"name\":\"Cardiac Marker Testing Market worth $5.5 billion by 2025 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg\",\"datePublished\":\"2021-06-01T12:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiac Marker Testing Market worth $5.5 billion by 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiac Marker Testing Market worth $5.5 billion by 2025 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/","og_locale":"en_US","og_type":"article","og_title":"Cardiac Marker Testing Market worth $5.5 billion by 2025 - Business","og_description":"According to the new market research report&nbsp;&ldquo;Cardiac Marker Testing Market&nbsp;by Product (Reagent, Instrument), Component (Troponin I &amp; T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) &ndash; Global Forecasts to 2025&Prime;,&nbsp;published by MarketsandMarkets&trade;, the market is estimated to be&nbsp;USD 3.6 billion&nbsp;in 2020 and projected to reach&nbsp;USD 5.5 billion&nbsp;by [&hellip;] The post Cardiac Marker Testing Market worth $5.5 billion by 2025 appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/","og_site_name":"Business","article_published_time":"2021-06-01T12:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/","url":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/","name":"Cardiac Marker Testing Market worth $5.5 billion by 2025 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg","datePublished":"2021-06-01T12:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2019\/03\/1902-mnm_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/cardiac-marker-testing-market-worth-5-5-billion-by-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Cardiac Marker Testing Market worth $5.5 billion by 2025"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=115458"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115458\/revisions"}],"predecessor-version":[{"id":115459,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115458\/revisions\/115459"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=115458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=115458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=115458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}